Examine This Report on pentobarbital drug
Examine This Report on pentobarbital drug
Blog Article
pentobarbital will lower the extent or effect of fosamprenavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will reduce the level or influence of theophylline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will minimize the level or impact of naloxegol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with sturdy CYP3A4 inducers is not recommended
pentobarbital will lessen the level or effect of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Estradiol valerate/dienogest should not be applied for a minimum of 28 days after discontinuation from the inducer on account of likelihood of lowered contraceptive efficacy.
pentobarbital will lower the level or impact of triamcinolone acetonide injectable suspension by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will minimize the level or result of estropipate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the extent or result of ramelteon by affecting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Significance Not known.
pentobarbital will lessen the level or outcome of docetaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.
pentobarbital will lessen the extent or outcome of oliceridine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. If coadministration with a CYP3A4 inducer is check here necessary, take into consideration rising oliceridine dose until finally steady drug effects are reached; check for signs of opioid withdrawal.
Contraindicated (one)pentobarbital will lower the extent or influence of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or outcome of osilodrostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
With therapeutic doses of TCAs, barbiturates enhance metabolism and reduce blood concentrations of TCAs.
pentobarbital will minimize the level or impact of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.